Here’s what you should know.
1. Analysts projected $1.37 earnings per share in the third quarter. Stryker posted $1.39 earnings per share.
2. Stryker had $2.83 billion in revenue, a 23.96 percent return on net equity and a 15.24 percent net margin.
3. Quarterly revenue was up 17.1 percent on a year-over-year basis.
4. When it comes to market analysts, 12 gave Stryker a “buy” rating, nine a “hold” rating and three rated it as a “sell.”
More articles on orthopedics/spinal devices:
DePuy Synthes, Mazor, NuVasive & more: 20 key notes — NASS edition
DePuy Synthes unveils Zero-Profile Plate for spinal fusions: 5 things to know
Zimmer Biomet acquires RespondWell to strengthen home rehabilitation offering: 4 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
